Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
Background: Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied. Aim: The objective of the study was to investigate whether angiopoietin-2 levels are associated...
Saved in:
Main Authors: | Luxmipratha Rajendiran (Author), Hanumanthappa Nandeesha (Author), Thyagaraju Chitra (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Laparoscopic ovarian drilling reduces testosterone and luteinizing hormone/follicle-stimulating hormone ratio and improves clinical outcome in women with polycystic ovary syndrome
by: Priyanka Sinha, et al.
Published: (2019) -
Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: A cross-sectional study
by: Sreelalitha Kayali, et al.
Published: (2022) -
Comparison of clinical, metabolic, hormonal, and ultrasound parameters among the clomiphene citrate-resistant and clomiphene citrate-sensitive polycystic ovary syndrome women
by: Garima Sachdeva, et al.
Published: (2019) -
Metformin With or Without Clomiphene Citrate Versus Laparoscopic Ovarian Drilling With or Without Clomiphene Citrate to Treat Patients With Clomiphene Citrate-Resistant Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
by: Ming-Li Sun, et al.
Published: (2022) -
Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
by: Aqueela Ayaz, et al.
Published: (2013)